On the public citation graph
Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy
0 signed · 55 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ddr.20291openalex-snapshot
Structure and modeling in the design of β‐ and γ‐secretase inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2006.12.061openalex-snapshot
A quantitative assessment of hERG liability as a function of lipophilicity
inferredcites →https://doi.org/10.1016/j.bmcl.2009.04.033openalex-snapshot
Discovery of aminoheterocycles as a novel β-secretase inhibitor class: pH dependence on binding activity part 1
inferredcites →https://doi.org/10.1016/j.bmcl.2009.09.103openalex-snapshot
Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening
inferredcites →https://doi.org/10.1016/j.bmcl.2010.06.089openalex-snapshot
Fragment-based discovery and optimization of BACE1 inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2010.07.140openalex-snapshot
Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
inferredcites →https://doi.org/10.1016/j.bmcl.2010.09.029openalex-snapshot
Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability
inferredcites →https://doi.org/10.1016/j.bmcl.2011.10.050openalex-snapshot
Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2012.01.079openalex-snapshot
Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy
inferredcites →https://doi.org/10.1016/j.drudis.2006.12.003openalex-snapshot
Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective
inferredcites →https://doi.org/10.1016/j.drudis.2011.10.005openalex-snapshot
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
inferredcites →https://doi.org/10.1016/j.jalz.2012.02.001openalex-snapshot
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
inferredcites →https://doi.org/10.1016/j.jalz.2012.05.347openalex-snapshot
P1‐071: Intensity of dementia through latent variable modelling (I‐DeLV) in the AIBL cohort
inferredcites →https://doi.org/10.1016/j.tips.2012.02.003openalex-snapshot
Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond
inferredcites →https://doi.org/10.1021/ci400374zopenalex-snapshot
Potency Prediction of β-Secretase (BACE-1) Inhibitors Using Density Functional Methods
inferredcites →https://doi.org/10.1021/jm00334a001openalex-snapshot
A Mathematical Contribution to Structure-Activity Studies
inferredcites →https://doi.org/10.1021/jm050499dopenalex-snapshot
Discovery of Cell-Permeable Non-Peptide Inhibitors of β-Secretase by High-Throughput Docking and Continuum Electrostatics Calculations
inferredcites →https://doi.org/10.1021/jm0607451openalex-snapshot
Acylguanidines as Small-Molecule β-Secretase Inhibitors
inferredcites →https://doi.org/10.1021/jm070825kopenalex-snapshot
Discovery of a Novel Warhead against β-Secretase through Fragment-Based Lead Generation
inferredcites →https://doi.org/10.1021/jm070829popenalex-snapshot
Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency
inferredcites →https://doi.org/10.1021/jm3009025openalex-snapshot
Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides
inferredcites →https://doi.org/10.1021/jm300991nopenalex-snapshot
New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain
inferredcites →https://doi.org/10.1021/jm3011349openalex-snapshot
Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity
inferredcites →https://doi.org/10.1021/jm701122qopenalex-snapshot
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
inferredcites →https://doi.org/10.1021/jm901408popenalex-snapshot
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation
inferredcites →https://doi.org/10.1021/ml3001165openalex-snapshot
Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction
inferredcites →https://doi.org/10.1038/nature11283openalex-snapshot
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
inferredcites →https://doi.org/10.1038/nrneurol.2009.218openalex-snapshot
The secretases: enzymes with therapeutic potential in Alzheimer disease
inferredcites →https://doi.org/10.1046/j.1432-1327.1998.2510252.xopenalex-snapshot
A general pattern for substrate recognition by P‐glycoprotein
inferredcites →https://doi.org/10.1056/nejmra032426openalex-snapshot
Drug-Induced Prolongation of the QT Interval
inferredcites →https://doi.org/10.1080/10629360412331297353openalex-snapshot
Prediction of hERG K+ blocking potency: Application of structural knowledge
inferredcites →https://doi.org/10.1111/j.1471-4159.2011.07476.xopenalex-snapshot
Developing β‐secretase inhibitors for treatment of Alzheimer’s disease
inferredcites →https://doi.org/10.1111/j.1747-0285.2011.01087.xopenalex-snapshot
Sequential Virtual Screening Approach to the Identification of Small Organic Molecules as Potential BACE‐1 Inhibitors
inferredcites →https://doi.org/10.1126/science.1072994openalex-snapshot
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
inferredcites →https://doi.org/10.1126/science.1566067openalex-snapshot
Alzheimer's Disease: The Amyloid Cascade Hypothesis
inferredcites →https://doi.org/10.1126/science.286.5440.735openalex-snapshot
β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
inferredcites →https://doi.org/10.1146/annurev.neuro.21.1.479openalex-snapshot
MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
inferredcites →https://doi.org/10.1517/13543776.2012.681302openalex-snapshot
Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
inferredcites →https://doi.org/10.1523/jneurosci.3647-11.2011openalex-snapshot
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
inferredcites →https://doi.org/10.2174/156802609787521571openalex-snapshot
Recent Advances in Medicinal Chemistry and Pharmaceutical Technology- Strategies for Drug Delivery to the Brain
inferredcites →https://doi.org/10.2174/157340909788451928openalex-snapshot
In Silico hERG Modeling: Challenges and Progress
inferredcites →https://doi.org/10.2174/157488911795933938openalex-snapshot
BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on Bioactivity
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/ange.201814681openalex-snapshot
Automated De Novo Drug Design: Are We Nearly There Yet?
inferred← citeshttps://doi.org/10.1002/anie.201814681openalex-snapshot
Automated De Novo Drug Design: Are We Nearly There Yet?
inferred← citeshttps://doi.org/10.1002/chem.201501662openalex-snapshot
A Versatile Approach to CF3‐Containing 2‐Pyrrolidones by Tandem Michael Addition–Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors
inferred← citeshttps://doi.org/10.1002/chem.202005262openalex-snapshot
Diastereoselective Synthesis of Functionalized 5‐Amino‐3,4‐Dihydro‐2H‐Pyrrole‐2‐Carboxylic Acid Esters: One‐Pot Approach Using Commercially Available Compounds and Benign Solvents
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.13809-0openalex-snapshot
Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.12.092openalex-snapshot
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.bpc.2015.03.006openalex-snapshot
Structural insight into the mechanism of amyloid precursor protein recognition by β-secretase 1: A molecular dynamics study
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2014.10.019openalex-snapshot
Probucol mitigates streptozotocin-induced cognitive and biochemical changes in mice
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01101openalex-snapshot
1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads
inferred← citeshttps://doi.org/10.1021/acscatal.3c05824openalex-snapshot
Gold-Catalyzed N-Alkenylation of Isoxazolines and the Use of Alkenyl Gold Intermediates in the Synthesis of 2-Amino-1-pyrrolines
inferred← citeshttps://doi.org/10.1021/ci400374zopenalex-snapshot
Potency Prediction of β-Secretase (BACE-1) Inhibitors Using Density Functional Methods
inferred← citeshttps://doi.org/10.1021/ci5006355openalex-snapshot
Evaluation of a Semi-Automated Workflow for Fragment Growing
inferred← citeshttps://doi.org/10.3390/ijms25136890openalex-snapshot
Network Models of BACE-1 Inhibitors: Exploring Structural and Biochemical Relationships
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.